Fact checked byGina Brockenbrough, MA

Read more

August 16, 2022
1 min read
Save

Gore acquires InnAVasc Medical

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

W. L. Gore & Associates Inc. is acquiring InnAVasc Medical Inc., a medical technology company focused on developing vascular access grafts for patients with end-stage renal disease, according to a press release.

“The addition of InnAVasc’s investigational technology bolsters our continued ambition to improve patients’ lives by offering physicians innovative treatment solutions within the dialysis access space,” Eric Zacharias, head of the medical products division at Gore, said in a press release. “We are excited about InnAVasc’ s unique technology and its potential to advance patient care for those with ESRD. This acquisition reinforces Gore’s commitment to innovation and desire to be strong partners in advancing treatments for these patients.”

The InnAVasc device is currently in clinical trials and not available for commercial use.

Developed by Jeffrey Lawson, MD, PhD, and Shawn Gage, PA-C, at Duke University School of Medicine’s Department of Surgery, the InnAVasc graft “is designed to allow for safe, easy, reproduceable and durable access for dialysis treatment of patients with graft circuits,” Gore said in the release. “The investigational InnAVasc device is designed to protect the graft from backwall punctures and reduce the damage associated with frequent needle sticks which occur over the lifespan of a dialysis graft. This can lead to circuit failure and shortened circuit life.”

“To be stuck with two needles three times a week for hemodialysis for 52 weeks, that's 312 times a needle goes into a patient’s graft each year,” Stephen Hohmann, MD, a vascular surgeon at Texas Vascular Associates, said in the release. “So having a graft that has the ability to decrease risk potential and long-term injury is definitely something that would be a game changer.”

Reference:

Gore acquires InnAVasc Medical Inc. www.gore.com/news-events/press-release/gore-acquires-innavasc-medical. Published Aug. 12, 2022. Accessed Aug. 16, 2022.